Roche's virtual event on key data presented at the 2021 MDA Virtual Clinical & Scientific Conference

Roche has hosted a virtual event on Friday, 19th March 2021.


  • Phase II/III SUNFISH part 2: 24-month efficacy and safety of risdiplam in patients with Type 2 or non-ambulant Type 3 spinal muscular atrophy
    Paulo Fontoura, M.D. Ph.D., Global Head Neuroscience and Rare Diseases Clinical Development
  • Roche Neuroscience and Rare Disease franchise update
    Simona Skerjanec, Therapeutic Area Head Neuroscience and Rare Diseases, Global Product Strategy
  • Q&A
    Karl Mahler, Head of Investor Relations and Roche Group Planning

Please register to access the webcast*

* Privacy notice

* Mandatory


The registration form for the webcast is not available.


Please come back 30 minutes before the webcast start date and fill in the registration form.